Sign in

Deepak Madhavanan

Research Analyst at UBS

Deepak Madhavanan is an Executive Director and Senior Equity Research Analyst at UBS, specializing in healthcare services and medical technology coverage, with a focus on companies such as Agilon Health, DaVita, Humana, and UnitedHealth Group. He has consistently ranked among the top analysts in his sector, with TipRanks listing a success rate of approximately 71% and an average return of over 14% per rating, establishing a strong performance track record. Deepak began his equity research career at Barclays after completing an MBA at Kellogg Northwestern, before joining UBS in 2017 and advancing to his current senior role. He is FINRA-registered, holding Series 7, 63, 86, and 87 licenses, reflecting robust professional and regulatory credentials.

Deepak Madhavanan's questions to Spotify Technology (SPOT) leadership

Question · Q3 2025

Deepak Madhavanan asked if Spotify sees an opportunity to help artists with AI tools for music creation and about Spotify's strategy to enable AI tools for creators, given the advancements in AI models for video and audio.

Answer

Gustav Söderström, Co-President, CPO, and CTO, confirmed that Spotify sees this opportunity and aims to be a responsible enabler of AI tools for artists, allowing them to participate and choose to use these tools. He emphasized that this applies not only to music but also to podcasters and authors.

Ask follow-up questions

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%